Nutraceuticals

Section I. Applications of nutraceuticals in common diseases and disorders 1. Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection 2. Prevention of neurodegenerative disorders by nutraceuticals 3. Cognitive effects of nutraceuticals 4. Nutraceuticals in anxiety and stress 5. Countering cardiovascular diseases with nutraceuticals 6. Nutraceuticals for diabetes and glucose balance 7. Role of nutraceuticals in respiratory and allied diseases 8. Nutraceuticals in hepatic diseases 9. Nutraceuticals in renal diseases 10. Nutraceuticals in gastrointestinal disorders 11. Nutraceuticals in reproductive and developmental disorders 12. Nutraceuticals in ophthalmic diseases 13. Nutraceuticals in dermal diseases14. Nutraceuticals in arthritis 15. Nutraceuticals in sports activities and fatigue 16. Role of nutraceuticals as adaptogens 17. Nutraceuticals for weight loss 18. Nutraceuticals in cancer prevention19. Application of "nano nutraceuticals in medicine Section II. Models and mechanisms in evaluation of nutraceuticals 20. The biology of nutrients: genetic and molecular principles 21. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals 22. Transcriptomic profiling for safety and toxicity evaluation ofnutraceuticals 23. Target identification and polypharmacology of nutraceuticals 24. Systems pharmacology investigation of mechanism of action of nutraceuticals25. Noninvasive in vivo optical imaging models for safety and toxicity testing 26. Flow cytometry and light-scattering techniques in evaluation of nutraceuticals 27. Zebrafish as a model system to evaluate the safety and toxicity of nutraceuticals28. Caenorhabditis elegans: an elegant model organism for evaluating the neuroprotective and neurotherapeutic potential of nutraceuticals 29. Alternative in vitro models for safety and toxicity evaluation of nutraceuticals30. Mitochondria as a target for safety and toxicity evaluation of nutraceuticals31. Oxidative stress and excitotoxicity: antioxidants from nutraceuticalsSection III. Common nutraceuticals32. Caffeine: an evaluation of the safety database 33. Biological activities and potential nanotechnological delivery of resveratrol 34. Melatonin: a safe nutraceutical and clinical agent35. Standardized turmeric and curcumin 36. Curcuminoid-metal complexes for oxidative stress37. Fenugreek: multiple health benefits38. Cannabis sativa: an overview39. Cannabidiol safety40. St John's wort (Hypericum perforatum L)41. Green tea 42. Green coffee beans43. Quercetin44. German chamomile 45. Isoflavones: toxicological aspects and efficacy 46. Propolis 47. Bee products as nutraceuticals to nutraceuticals for bees 48. Ginkgo biloba 49. Chinese ginseng 50. Ashwagandha: multiple health benefits 51. Astaxanthin: health benefits and toxicity 52. Thymoquinone 53. Glucosinolates54. Organosulfur compounds as nutraceuticals55. Arginine and citrulline as nutraceuticals: efficacy and safety in diseases 56. Neem Extract57. Spirulina 58. Garcinia cambogia 59. Vitamin E TPGS and its applications in nutraceuticals60. Role of transferrin: an iron-binding protein in health and diseases 61. Glutamine supplementation: hope, hype, or stay tuned? 62. What to do with placenta after birth: is it a waste? 63. Chitin, chitosan, and their derivatives Section IV. Prebiotics and probiotics 64. Prebiotics: safety and toxicity considerations65. Probiotics: safety and toxicity considerations66. Synbiotics: safety and toxicity considerations Section V. Nutraceuticals in veterinary medicine 67. Nutraceuticals in animal health and diseases Section VI. Toxicity and toxic interactions 68. Toxic contamination of nutraceuticals and food ingredients 69. Nutraceuticals and adverse outcome pathways 70. Interactions between nutraceuticals/nutrients and nutrients and therapeutic drugs 71. Genotoxicity evaluation of nutraceuticals Section VII. Regulatory aspects 72.